BryoLogyx Increases Antigen Visibility for an Enhanced I-O Impact

Bryostatin-1 increases antigen expression on the surface of cancer cells, enabling them to be seen and killed by IO agents.

Related Keywords

Paul Wender ,Tom Loarie ,Development Agreement ,National Cancer Institute ,A Cooperative Research ,University Of Rochester ,Stanford University ,Family Office ,Force Family Office ,Cooperative Research ,Immuno Oncology ,